Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 8, 2009
HANSEN MEDICAL, INC.
(Exact name of registrant as specified in charter)
         
Delaware   001-33151   14-1850535
(State or other jurisdiction of
incorporation)
  (Commission File Number)   (I.R.S. Employer Identification
No.)
800 East Middlefield Road
Mountain View, California 94043

(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (650) 404-5800
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 2.02. Results of Operations and Financial Condition
Item 9.01. Financial Statements and Exhibits
SIGNATURES
EX-99.1


Table of Contents

Item 2.02. Results of Operations and Financial Condition.
     On January 8, 2009, Hansen Medical, Inc. issued a press release announcing preliminary revenue results for the quarter ended December 31, 2008. A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.
     The information in this current report and in the accompanying exhibit shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this current report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Hansen Medical, Inc, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
     
Exhibit    
No.   Description
99.1
  Press release, dated January 8, 2009, entitled “Hansen Medical Announces Preliminary Fourth Quarter 2008 Revenue Results and Provides Preliminary 2009 Outlook.”

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
         
  Hansen Medical, Inc.
(Registrant)
 
 
Date: January 8, 2009  /s/ Steven M. Van Dick    
  Steven M. Van Dick   
  Chief Financial Officer    
 

 

Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.